Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report
{{output}}
Abacavir is a nucleoside analogue reverse transcriptase inhibitor used in combination with other antiretroviral drugs for the treatment of HIV 1-infection. Approximately 3% of patients who receive abacavir develop an idiosyncratic hypersensitivity reaction. Th... ...
